|
Items where Subject is "QZ Pathologie, Onkologie"
Wechseln zu: B | G | H | K | L | P | S | ZAnzahl der Einträge auf dieser Ebene: 11. B
Bader, Till und Schima, Wolfgang
Bader Till, Vorsitz 7.Sitzung: Tumore.
Kongresstag Radiologie und Nuklearmedizin. Muskuloskettale Bildgebung., 26.04.2019, OSS. [Vorsitz]
Item not available from this repository.
|
|
Bruns, Jürgen, Ewerbeck, Volker, Dominkus, Martin, Windhager, Reinhard, Hassenpflug, Joachim, Windhagen, Henning, Hovy, L, Loehr, J, Krauspe, R und Duerr, Hans Roland
(2013)
Pigmented villo-nodular synovitis and giant-cell tumor of tendon sheaths: a binational retrospective study.
Arch Orthop Trauma Surg, 133.
pp. 1047-1053.
|
![238 PVS-Paper.pdf [thumbnail of 238 PVS-Paper.pdf]](https://eprints.vinzenzgruppe.at/6721/1.hassmallThumbnailVersion/238%20PVS-Paper.pdf)  Vorschau
|
G
Gerum, S, Iglseder, W, Schmid, R, Peterka, K, Knocke-Abulesz, T H, Harl, P, Schwaiger, S, Reiter, I, Salinger, J, Venhoda, C, Kurzweil, G, Poetscher, M, Jaeger, R, Celedin, B, Clemens, P und Roeder, F
(2021)
Practice of radiation therapy for anal cancer in Austria-a survey on behalf of the Austrian radiation oncology society gastrointestinal tumor group (ÖGRO-GIT).
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 197 (11).
pp. 953-961.
ISSN 1439-099X
|
![66_2021_Article_1842.pdf [thumbnail of 66_2021_Article_1842.pdf]](https://eprints.vinzenzgruppe.at/9615/1.hassmallThumbnailVersion/66_2021_Article_1842.pdf)  Vorschau
|
H
Haderlein, Marlen, von der Grün, Jens, Balermpas, Panagiotis, Rödel, Claus, Hautmann, Matthias G, Steger, Felix, Bohr, Christopher, Hehr, Thomas, Stromberger, Carmen, Budach, Volker, Schymalla, Markus, Engenhart-Cabillic, Rita, Kocik, Lukas, Geinitz, Hans, Nestle, Ursula, Klautke, Gunter, Scherl, Claudia, Gall, Christine, Frey, Benjamin, Schubert, Philipp, Semrau, Sabine, Ott, Oliver, Kesting, Marco, Iro, Heinrich, Mueller, Sarina K und Fietkau, Rainer
(2024)
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial).
Frontiers in oncology, 14.
p. 1447123.
ISSN 2234-943X
|
![Haderlein DIREKHT Studie Front Oncol 2024.pdf [thumbnail of Haderlein DIREKHT Studie Front Oncol 2024.pdf]](https://eprints.vinzenzgruppe.at/10575/1.hassmallThumbnailVersion/Haderlein%20DIREKHT%20Studie%20Front%20Oncol%202024.pdf)  Vorschau
|
Hecht, M, Meier, F, Zimmer, L, Polat, B, Loquai, C, Weishaupt, C, Forschner, A, Gutzmer, R, Utikal, JS, Goldinger, SM, Geier, M, Hassel, JC, Balermpas, P, Kiecker, F, Rauschenberg, R, Dietrich, U, Clemens, P, Berking, C, Grabenbauer, G, Schadendorf, D, Grabbe, S, Schuler, G, Fietkau, R, Disel, LV und Heinzerling, L
(2018)
Clinical outcome of concomitant vs interrupted BRAF Inhibitor therapy during radiotherapy in melanoma patients.
British Journal Cancer, 118 (6).
pp. 785-792.
Item not available from this repository.
|
|
K
Kroeze, Stephanie G C, Fritz, Corinna, Schaule, Jana, Blanck, Oliver, Kahl, Klaus Henning, Kaul, David, Siva, Shankar, Gerum, Sabine, Claes, An, Sundahl, Nora, Adebahr, Sonja, Stera, Susanne, Schymalla, Markus M, Abbasi-Senger, Nasrin, Buergy, Daniel, Geier, Michael, Szuecs, Marcella, Lohaus, Fabian, Henke, Guido, Combs, Stephanie E und Guckenberger, Matthias
(2021)
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis.
Cancers, 13 (19).
ISSN 2072-6694
|
![cancers-13-04780.pdf [thumbnail of cancers-13-04780.pdf]](https://eprints.vinzenzgruppe.at/9617/1.hassmallThumbnailVersion/cancers-13-04780.pdf)  Vorschau
|
Kroeze, Stephanie G C, Schaule, Jana, Fritz, Corinna, Kaul, David, Blanck, Oliver, Kahl, Klaus H, Roeder, Falk, Siva, Shankar, Verhoeff, Joost J C, Adebahr, Sonja, Schymalla, Markus M, Glatzer, Markus, Szuecs, Marcella, Geier, Michael, Skazikis, Georgios, Sackerer, Irina, Lohaus, Fabian, Eckert, Franziska und Guckenberger, Matthias
(2021)
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database.
Radiation oncology (London, England), 16 (1).
p. 4.
ISSN 1748-717X
|
![13014_2020_Article_1730.pdf [thumbnail of 13014_2020_Article_1730.pdf]](https://eprints.vinzenzgruppe.at/9614/1.hassmallThumbnailVersion/13014_2020_Article_1730.pdf)  Vorschau
|
L
P
Pichler, Josef, Traub-Weidinger, Tatjana, Spiegl, Kurt, Imamovic, Larisa, Braat, Arthur J A T, Snijders, Tom J, Verhoeff, Joost J C, Flamen, Patrick, Tauchmanova, Libuse, Hayward, Colin und Kluge, Andreas
(2024)
Results from a phase I study of 4-<i>l</i>-[131I]iodo-phenylalanine ([<sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
Neuro-oncology advances, 6 (1).
vdae130.
ISSN 2632-2498
|
![Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf [thumbnail of Pichler Results from a phase I study IPAX-1 Neurooncol Advanc 2024.pdf]](https://eprints.vinzenzgruppe.at/10576/1.hassmallThumbnailVersion/Pichler%20Results%20from%20a%20phase%20I%20study%20IPAX-1%20Neurooncol%20Advanc%202024.pdf)  Vorschau
|
S
Schuster, Barbara, Hecht, Markus, Schmidt, Manfred, Haderlein, Marlen, Jost, Tina, Büttner-Herold, Maike, Weber, Klaus, Denz, Axel, Grützmann, Robert, Hartmann, Arndt, Geinitz, Hans, Fietkau, Rainer und Distel, Luitpold V
(2021)
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer.
Cancers, 14 (1).
ISSN 2072-6694
|
![cancers-14-00148.pdf [thumbnail of cancers-14-00148.pdf]](https://eprints.vinzenzgruppe.at/9616/1.hassmallThumbnailVersion/cancers-14-00148.pdf)  Vorschau
|
Z
Zehentmayr, Franz, Feurstein, Petra, Ruznic, Elvis, Langer, Brigitte, Grambozov, Brane, Klebermass, Marisa, Hüpfel, Herbert, Feichtinger, Johann, Minasch, Danijela, Heilmann, Martin, Breitfelder, Barbara, Steffal, Claudia, Gastinger-Grass, Gisela, Kirchhammer, Karoline, Kazil, Margit, Stranzl, Heidi und Dieckmann, Karin
(2024)
Durvalumab impacts progression-free survival while high-dose radiation >66 Gy improves local control without excess toxicity in unresectable NSCLC stage III: Real-world data from the Austrian radio-oncological lung cancer study association registry (ALLSTAR).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 196.
p. 110294.
ISSN 1879-0887
|
![Feichtinger Durvalumab impacts progression free survival while high-dose radiation 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III Elsevier 2024.pdf [thumbnail of Feichtinger Durvalumab impacts progression free survival while high-dose radiation 66 Gy improves local control without excess toxicity in unresectable NSCLC stage III Elsevier 2024.pdf]](https://eprints.vinzenzgruppe.at/10574/1.hassmallThumbnailVersion/Feichtinger%20Durvalumab%20impacts%20progression%20free%20survival%20while%20high-dose%20radiation%2066%20Gy%20improves%20local%20control%20without%20excess%20toxicity%20in%20unresectable%20NSCLC%20stage%20III%20Elsevier%202024.pdf)  Vorschau
|
Diese Liste wurde am Sun Mar 9 03:00:51 2025 UTC generiert.
|
|